Background Compulsory urine testing of prisoners for drugs, a control initiative, was introduced in eight prisons in England and Wales early in 1995.
Despite no evidence of effectiveness, testing was extended to all prisons in England and Wales by March 1996.
We consider the cost of testing.
Methods We combined the costs of refusals, confirmatory tests, punishment of confirmed positives for cannabis or for class A drugs to estimate the average costs of random compulsory drugs testing.
These costs were then compared to : i) the healthcare budget for a prison ; and ii) the cost of putting in place a credible prisons'drugs reduction programme.
We then used Scottish data on incarceration and regional prevalence of injecting drug users to estimate the extent of the injecting drug use problem that prisons face.
Findings Costs per 28 days of the random mandatory drugs testing control initiative in an establishment for 500 inmates where refusal rate is a) 10% or b) nil ; and 35% of urine samples test positive, one tenth of them for class A drugs were estimated at between a) £UK22 800 and b) £UK16000 per 28 days [a) $US35100 and b) $US24600]. This cost was equivalent to twice the cost of running a credible drugs reduction and rehabilitation programme, and around half the total healthcare expenditure for a prison of 500 which averaged £UK41114 per 28 days [$US64860]. (...)
Mots-clés Pascal : Toxicomanie, Dépistage, Milieu carcéral, Coût, Urine, Programme sanitaire, Prévention, Angleterre, Grande Bretagne, Royaume Uni, Europe, Pays de Galles, Etude comparative, Economie, Homme, Economie santé
Mots-clés Pascal anglais : Drug addiction, Medical screening, Carceral environment, Costs, Urine, Sanitary program, Prevention, England, Great Britain, United Kingdom, Europe, Wales, Comparative study, Economy, Human, Health economy
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 96-0505894
Code Inist : 002B03D. Création : 10/04/1997.